Indirect Effects of the COVID-19 Pandemic on In-Hospital Outcomes among Internal Medicine Departments: A Double-Center Retrospective Study

Author:

Di Marco Maurizio1ORCID,Miano Nicoletta1ORCID,Marchisello Simona1ORCID,Coppolino Giuseppe1,L’Episcopo Giuseppe1,Scilletta Sabrina1ORCID,Spichetti Concetta1,Torre Serena1,Scicali Roberto1ORCID,Zanoli Luca1ORCID,Gaudio Agostino1ORCID,Castellino Pietro1,Piro Salvatore1ORCID,Purrello Francesco1,Di Pino Antonino1

Affiliation:

1. Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy

Abstract

The coronavirus disease 19 (COVID-19) emergency led to rearrangements of healthcare systems with a significant impact on those internal medicine departments that had not been converted to COVID-19 wards. A reduced number of departments, indeed, had to cope with the same number of patients along with a lack of management of patients’ chronic diseases. We conducted a retrospective study aimed at examiningthe consequences of the COVID-19 pandemic on internal medicine departments that were not directly managing COVID-19 patients. Data from 619 patients were collected: 247 subjects hospitalized in 2019 (pre-COVID-19 era), 178 in 2020 (COVID-19 outbreak era) and 194 in 2021 (COVID-19 ongoing era). We found that in 2020 in-hospital mortality was significantly higher than in 2019 (17.4% vs. 5.3%, p = 0.009) as well as length of in-hospital stay (LOS) (12.7 ± 6.8 vs. 11 ± 6.2, p = 0.04). Finally, we performed a logistic regression analysis of the major determinants of mortality in the entire study population, which highlighted an association between mortality, being bedridden (β = 1.4, p = 0.004), respiratory failure (β = 1.5, p = 0.001), glomerular filtration rate (β = −0.16, p = 0.03) and hospitalization in the COVID-19 outbreak era (β = 1.6, p = 0.005). Our study highlights how the COVID-19 epidemic may have caused an increase in mortality and LOS even in patients not directly suffering from this infection.

Publisher

MDPI AG

Subject

General Medicine

Reference42 articles.

1. WHO (2022, June 07). Coronavirus (COVID-19) Dashboard. Available online: https://covid19.who.int.

2. Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, 23 March–12 May 2020;Reed;JAMA Intern. Med.,2020

3. Metzger, C., Leroy, T., Bochnakian, A., Jeulin, H., Gegout-Petit, A., Legrand, K., Schvoerer, E., and Guillemin, F. (2023). Seroprevalence and SARS-CoV-2 Invasion in General Populations: A Scoping Review over the First Year of the Pandemic. PLoS ONE, 18.

4. The Untold Toll—The Pandemic’s Effects on Patients without COVID-19;Rosenbaum;N. Engl. J. Med.,2020

5. (2022). COVID-19 Excess Mortality Collaborators Estimating Excess Mortality Due to the COVID-19 Pandemic: A Systematic Analysis of COVID-19-Related Mortality, 2020–2021. Lancet, 399, 1513–1536.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3